학술논문
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
Document Type
Article
Author
Monin, Leticia ; Laing, Adam G ; Muñoz-Ruiz, Miguel ; McKenzie, Duncan R ; del Molino del Barrio, Irene ; Alaguthurai, Thanussuyah ; Domingo-Vila, Clara; Hayday, Thomas S; Graham, Carl; Seow, Jeffrey; Abdul-Jawad, Sultan; Kamdar, Shraddha; Harvey-Jones, Elizabeth; Graham, Rosalind; Cooper, Jack; Khan, Muhammad; Vidler, Jennifer; Kakkassery, Helen; Sinha, Shubhankar; Davis, Richard; Dupont, Liane; Francos Quijorna, Isaac; O'Brien-Gore, Charlotte; Lee, Puay Ling; Eum, Josephine; Conde Poole, Maria; Joseph, Magdalene; Davies, Daniel; Wu, Yin; Swampillai, Angela; North, Bernard V; Montes, Ana; Harries, Mark; Rigg, Anne; Spicer, James; Malim, Michael H; Fields, Paul; Patten, Piers; Di Rosa, Francesca; Papa, Sophie; Tree, Timothy; Doores, Katie J; Hayday, Adrian C ; Irshad, Sheeba
Source
In The Lancet Oncology June 2021 22(6):765-778
Subject
Language
ISSN
1470-2045